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BACKGROUND: This study aimed to investigate longitudinal physiological changes in the recanalized coronary chronic total oc-
clusion (CTO) vessel and its dependent myocardium after successful percutaneous coronary intervention (PCI).
METHODS AND RESULTS: In this pilot study, 25 patients scheduled for elective CTO PCI with viable myocardium and angiographi-
cally visible collaterals were included. Absolute coronary blood flow and absolute microvascular resistance were measured 
invasively using continuous thermodilution. Measurements were performed immediately after successful CTO PCI and at 
short- term follow- up. In a subgroup of patients, physiological measurements were performed at the predominant donor ves-
sel before CTO PCI, immediately afterwards, and at follow- up. Absolute coronary blood flow in the recanalized CTO artery 
increased from 148±53 mL/min immediately after PCI to 221±77 mL/min at follow- up (P<0.001). In agreement, absolute re-
sistance in the myocardial territory perfused by the CTO artery, decreased from 545±255 Wood units immediately after the 
procedure to 387±128 Wood units at follow- up (P=0.014). There were no significant changes in the absolute coronary blood 
flow and resistance in the predominant donor between baseline and follow- up. Positive remodeling of the distal CTO vessel 
with an increase in lumen diameter was observed.
CONCLUSIONS: After successful CTO PCI, blood flow in the recanalized artery and microvascular function of the dependent 
myocardium are not immediately normal but recover over time.
Key Words: chronic total coronary occlusion ■ coronary flow ■ coronary microvascular function ■ coronary microvascular resistance  
■ coronary revascularization
Successful percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) relieves ischemia, improving patients’ symptoms, func-
tional status, and quality of life.1–4 It has been recog-
nized that after successful recanalization of a CTO, 
there is no immediate complete recovery of the dis-
tal artery and the dependent myocardial territory, 
but its function might improve over time.5–7 In most 
CTOs with viable distal myocardium, collateral blood 
supply is present and sufficient to maintain resting 
metabolism (hibernation) or even contraction at rest. 
However, evident ischemia occurs with increasing 
demand during stress/exercise.8,9 Due to reduced 
blood flow and perfusion pressure, negative remod-
eling of the distal part of the occluded vessel occurs, 
while microvascular changes become present in the 
distal myocardium, with an increase in microvascu-
lar resistance in the CTO territory. Both phenomena 
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contribute to incomplete, delayed, and suboptimal 
recovery of physiology even after technically suc-
cessful PCI.
A recent study showed that fractional flow reserve 
(FFR) of both the coronary artery and the myocardium 
of a recanalized CTO, increased over time, paralleled 
by regression of collaterals.10 These observations 
strongly suggest that recovery of both the distal cor-
onary artery and the dependent myocardium often 
occurs because an increase in FFR (without addi-
tional intervention in the epicardial artery) implicates 
a decrease of distal epicardial resistance. Although 
this study provides indirect evidence of recovery of 
microvascular function over time along with the pos-
itive remodeling of the distal CTO artery, there were 
no direct measurements of microvascular function or 
coronary blood flow.
Recently, a novel methodology has become avail-
able that allows accurate and quantitative invasive 
measurements of absolute coronary blood flow and 
resistance during coronary catheterization.11,12
The aim of the present study was to perform such 
serial measurements of absolute coronary flow and 
microvascular resistance in the recanalized CTO and 
major donor vessels after successful PCI. Based upon 
the observations of the present study in combination 
with the previous work by Karamasis et al,10 we aimed 
to propose a complete model explaining the physio-
logic changes after successful CTO PCI.
METHODS
Study Design and Population
This was a prospective observational exploratory 
study on coronary physiology after CTO percutane-
ous revascularization. Patients with a clinical indication 
for elective CTO PCI were recruited in the Catharina 
Hospital (Eindhoven, The Netherlands) and the Essex 
Cardiothoracic Centre (Basildon, UK). All patients had 
stable angina and viability of the myocardial territory 
supplied by the CTO vessel as evidenced by perfusion 
cardiac magnetic resonance imaging or preserved 
wall motion on transthoracic echocardiography at rest. 
As cardiac magnetic resonance criteria for ischemia 
and viability, >10% ischemic burden in the CTO ter-
ritory was the cutoff that we used to justify CTO PCI. 
Delayed myocardial enhancement was the cardiac 
magnetic resonance sequence used for viability and 
>75% with delayed enhancement in the myocardial 
segment under interrogation was the cutoff for a terri-
tory to be considered not viable. In all cases, there were 
spontaneously visible collateral vessels supplied by a 
contralateral donor artery. All patients provided written 
informed consent, and the study was approved by the 
local ethics committee in Eindhoven (The Netherlands) 
and Basildon (United Kingdom). The data that support 
the findings of this study are available from the corre-
sponding author upon reasonable request.
Chronic Total Occlusion PCI
CTO PCI was performed according to contemporary 
interventional techniques following the hybrid algo-
rithm. Recanalization strategy was left at the discre-
tion of the CTO operator. A procedure was considered 
successful if thrombolysis in myocardial infarction 
flow grade 3 with <30% angiographic residual ste-
nosis in the CTO vessel was achieved. Patients were 
discharged on statins and on dual antiplatelet therapy 
(aspirin and clopidogrel) for at least 1 year.
Measurement of Absolute Blood Flow and 
Microvascular Resistance
After successful PCI of the CTO, complete physiolog-
ical assessment in the recanalized vessel and its de-
pendent myocardium was performed by calculating 
CLINICAL PERSPECTIVE
What Is New?
• This study demonstrates that chronic total oc-
clusion physiology in the distal coronary artery 
and microvasculature does not normalize im-
mediately after successful chronic total occlu-
sion percutaneous coronary intervention but 
recovers over time.
What Are the Clinical Implications?
• Our findings provide the physiologic basis for 
justifying percutaneous coronary intervention of 
a chronic total occlusion artery in case of viable 
distal myocardium, indicated by either chest 
pain, a positive stress test, or preserved rest-
ing wall motion on the echocardiogram and ab-
sence of Q waves at the ECG.
Nonstandard Abbreviations and Acronyms
CTO chronic total occlusion
FFR fractional flow reserve
J-CTO Japanese Chronic Total Occlusion
PCI percutaneous coronary intervention
Q flow in mL/min
R resistance in Wood units
Ti infusion temperature in °C
WU Wood Units in mm Hg/L per min
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absolute coronary blood flow and microvascular re-
sistance using continuous thermodilution. The de-
tailed method was previously published.11–15 In brief, 
after intracoronary administration of nitroglycerin, a 
guidewire equipped with a pressure and tempera-
ture sensor (Pressure Wire X™, Abbott Vascular, St 
Paul, MN) is equalized at the tip of the guide cath-
eter and positioned in the distal vessel. Thereafter, a 
multifunctional monorail infusion catheter (RayFlow, 
Hexacath, Paris, France) is advanced over the wire 
and placed in the proximal coronary artery. The cath-
eter is connected to an infusion pump and saline in-
fusion at a prespecified flow rate (Qi, usually 20 mL/
min for the left anterior descending and left circum-
flex artery and 15 or 20 mL/min for the right coronary 
artery) is started. The distal temperature of the sa-
line/blood mixture is recorded automatically by the 
guidewire sensor. The saline infusion itself creates 
a state of maximum hyperemia within seconds12,16 
and when a steady hyperemic state is achieved the 
guidewire is pulled back to the tip of the catheter and 
the temperature of the infused saline (Ti) is meas-
ured. Absolute coronary flow during steady state 
maximum hyperemia (Q in mL/min) is calculated by 
assessment of the changes in distal coronary tem-
perature compared with the infusion temperature of 
the saline (Ti) by the equation Q=1.08
Ti
T
×Qi. The mi-
crovascular resistance (R in dyn.s.cm−5, mm  Hg/L 
per min, or Wood units [WU]) is calculated by dividing 
the distal coronary pressure (Pd) and the calculated 
blood flow (Q). Therefore, R is independent of the re-
sistance of the epicardial coronary artery, which can 
be assessed separately by (Pa- Pd)/Q. Live wireless 
recording and analysis of coronary pressure traces 
and temperature and automated calculation of Q and 
R is performed using a dedicated software system 
(Coroventis, Uppsala, Sweden).
Physiological Measurements in the Donor 
Vessel
In a subgroup of patients (n=10) with intermediate 
coronary disease (30%–70% stenosis) in the donor 
artery, physiological assessment including calcula-
tion of absolute flow and resistance as described 
above was performed in the predominant donor ves-
sel. The measurements were performed at the onset 
of the PCI procedure (before attempting the CTO 
vessel) and immediately after successful PCI of the 
CTO vessel.
Follow- Up Procedure
Patients with complete physiology measurements in 
the recanalized vessel returned for a follow- up proce-
dure within 2 months (7–70 days, mean 46 days) ac-
cording to institutional practice. During the follow- up 
procedure, absolute flow and resistance were meas-
ured once more in the recanalized CTO vessel fol-
lowing exactly the same method. In cases where 
measurements were performed in the predominant 
donor artery during the baseline procedure, these 
were also repeated. To evaluate recovery of coronary 
flow and microvasculature function of the CTO artery, 
we compared the measurements from the index pro-
cedure with those at follow- up. Figure 1 illustrates such 
complete sequence of angiographic and physiologic 
assessment in 1 patient.
Quantitative Angiographic Assessment of 
the Distal CTO Artery
Collateral circulation to the chronically occluded ves-
sel was graded using collateral connections grading 
method and the predominant donor vessel was deter-
mined. Procedure complexity was graded using the 
Japanese Multicenter CTO Registry score. After blind-
ing for clinical and procedural data, mean and minimal 
lumen diameter of the distal coronary artery were as-
sessed by quantitative coronary angiography after the 
baseline procedure and at follow- up. Quantitative cor-
onary analysis was performed using Philips Intellispace 
Cardiovascular Software System (Amsterdam, The 
Netherlands).
Statistical Analysis
Data were checked for normality of distribution 
using Kolmogorov–Smirnov testing. Categorical 
variables are presented as counts and percentages. 
Continuous variables are presented as mean±SD 
or median and interquartile range as appropriate. 
Comparisons of the relative change in absolute 
blood flow or resistance were made using a paired 
t- test. Spearman correlation coefficients were used 
to assess the relationship between 2 variables as ap-
propriate. ANOVA repeated measures test was per-
formed to assess the difference between 3 following 
measurements in the donor artery. A 2- tailed level of 
significance of 0.05 was used. All preceding analyses 
were performed using SPSS 25 software (SPSS Inc, 
Chicago, IL).
RESULTS
Twenty- five patients with successful CTO PCI and com-
plete physiology measurements in the recanalized vessel 
at baseline and follow- up were included. Baseline and 
procedural characteristics are listed in Table 1. The mean 
age was 66±8.7 years, and 19 of 25 patients were male. 
The most common CTO vessel was the right coronary 
artery and the mean Japanese–Chronic Total Occlusion 
score was 1.64±1.25. Antegrade wire escalation was the 
D
ow
nloaded from
 http://ahajournals.org by on April 30, 2020
J Am Heart Assoc. 2020;9:e015669. DOI: 10.1161/JAHA.119.015669 4
Keulards et al RECOVER CTO
most commonly successful recanalization technique 
(56%), followed by retrograde dissection/reentry (20%) 
(Table 2). The follow- up procedure was performed within 
2 months (7–70 days, mean 46 days). A subgroup of 10 
patients had physiology measurements of the predomi-
nant donor vessel at baseline and follow- up.
No major side effects of the absolute flow/resis-
tance measurement method were noted. Two patients 
showed rapidly transient atrioventricular block with a 
saline infusion rate of 20 mL/min in the right coronary 
artery. The atrioventricular block resolved immediately 
after the infusion was stopped. After adjustment of 
Figure 1. Typical case example.
Complete assessment of 1 patient at baseline and at follow- up. A and D, The CTO artery (right coronary artery) and the donor artery 
(left anterior descending) before PCI. The absolute flow in the donor vessel is 256 mL/min, with a resistance of 231WU. B, E, and G, 
Flow and resistance measured directly after PCI. C, F and H, At follow- up the CTO vessel showed an increase in flow from 161 mL/
min to 300 mL/min, and resistance of the dependent myocardium decreased from 370 to 243 WU. Flow in the donor artery decreased 
further. CTO indicates chronic total occlusion; FFR, fractional flow reserve; PCI, percutaneous coronary intervention; Q, absolute 
coronary flow during steady state maximum hyperemia; R, microvascular resistance; and WU, Wood units. Reprinted from Keulards et 
al17 with permission. Copyright ©2018, Europa Group.
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the infusion pump to a lower infusion rate (ie, less de-
crease of distal temperature), the measurements were 
completed without difficulty.
Absolute Coronary Blood Flow and 
Resistance Measurement
There was a significant increase in absolute blood 
flow in the CTO vessel over time in the overall co-
hort (Figure  2A). Flow in the recanalized CTO artery 
increased by 49% from 148±53 mL/min immediately 
after opening to 221±77 mL/min at follow- up (P<0.001). 
Absolute flow increased in 23 of the 25 cases. In 
agreement, absolute resistance in the myocardial ter-
ritory perfused by the CTO artery, decreased by 29% 
from 545±255 WU immediately after the procedure to 
387±128 WU at follow up (P=0.014) (Figure 2B). There 
were no significant changes in the absolute coronary 
blood flow and resistance in the predominant donor 
between baseline and follow- up. Absolute blood flow 
changed from 162 mL/min before PCI to 175 mL/min 
immediately after PCI and to 189 mL/min at follow- up 
(P=0.40). Microvascular resistance was 473 WU be-
fore PCI, 542 WU immediately after PCI and 474 WU 
at follow- up (P=0.44; Figure 3). In these 10 patients in 
whom donor vessel measurements were available, a 
net gain in summed absolute blood flow to the CTO 
and donor vessel myocardial territory of 118 mL/min 
was observed.
Assessment of Vessel Diameter Changes
All patients had complete follow- up quantitative coro-
nary analysis measurements. The distal CTO vessel 
lumen dimensions changed significantly from imme-
diately after PCI to follow- up. The minimal lumen di-
ameter increased from 1.17±0.39  mm to 1.42±0.45 
Table 1. Baseline Characteristics
Number of Patients (n=25) N (%) or Mean±SD
Male sex, N (%) 19 (76)
Age, mean (SD) 65.9±8.7
Medical history
Hypertension, n (%) 20 (80)
Current smoking, n (%) 4 (16)
Diabetes mellitus, n (%) 7 (28)
Dyslipidemia, n (%) 19 (76)
Previous myocardial infarction, n (%) 12 (48)
Clinical details
CCS angina class
I 7 (28)
II 8 (32)
III 8 (32)
VI 2 (8)
Left ventricular ejection fraction
<35% 0 (0)
35%- 50% 10 (40)
>50% 15 (60)
Angiographic details
Occluded target vessel
Right coronary artery 20 (80)
Left anterior descending artery 3 (12)
Left circumflex artery 2 (8)
Predominant donor vessel
Right coronary artery 5 (20)
Left anterior descending artery 17 (68)
Left circumflex artery 3 (12)
Collateral filling
Bridge collaterals 3 (12)
Retrograde filling 18 (72)
Both 4 (16)
Collateral size
CC0 2 (8)
CC1 17 (68)
CC2 6 (24)
J- CTO score
Tapered/blunt 5/10 (20/40)
Calcification present 15 (60)
Bending >45 degrees 5 (20)
Length >20 mm 11 (44)
Retry lesion 2 (8)
Total J- CTO- score
J- CTO 0 7 (28)
J- CTO 1 3 (12)
J- CTO 2 8 (32)
J- CTO 3 7 (28)
Total J- CTO score (mean, SD) 1.64±1.25
Summary values represent number (%) or mean±SD. CC indicates 
continuous connection; CCS, Canadian Cardiovascular Society; and J- CTO 
score, Japanese–Chronic Total Occlusion score.
Table 2. Procedural Characteristics
Number of Patients (n=25) N (%) or Mean±SD
Technique
Antegrade wire escalation 14 (56)
Retrograde wire escalation 4 (16)
Antegrade dissection and 
reentry
2 (8)
Retrograde dissection and 
reentry
5 (20)
Stent length 72.2±26
Other
Procedure time, min 136.3±78.1
Fluoroscopy time, min 39.2±26.3
Wire crossing time, min 53.4
Radiation dose area product, 
mGy
200 464±155 497
Summary values represent mean±standard deviation. mGy indicates 
milligray.
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(P<0.001). The mean lumen diameter increased from 
1.73 mm to 1.99 (P<0.05; Table 3). In parallel, epicardial 
resistance of the CTO artery calculated as (Pa- Pd)/Q, 
decreased by 17% from 82±55 WU to 68±49 WU 
(P=0.155; Table 3).
DISCUSSION
The present study is the first to perform sequential in-
vasive measurements of absolute hyperemic coronary 
blood flow and microvascular resistance immediately 
after successful CTO PCI and at short- term follow- up. 
The study showed that coronary blood flow and mi-
crocirculatory function of the dependent myocardium 
of a recanalized CTO, are still far from normal immedi-
ately after technically successful PCI and significantly 
improve over time. At the same time, significant luminal 
increase of the distal CTO vessel was observed. In a 
subgroup of patients where absolute blood flow and 
resistance were assessed at the predominant donor 
vessel, there was no change among measurements 
before CTO PCI, immediately afterward, and at short- 
term follow- up.
Novel techniques, advanced equipment, and in-
creasing operators’ experience in contemporary CTO 
PCI have resulted in high procedural success and low 
complications rates.18,19 However, target lesion failure 
remains higher compared with non- CTO angioplasty. 
Better understanding of physiological changes in the 
recanalized epicardial artery and the dependent myo-
cardium could potentially provide useful insight in op-
timization of the procedure and improving long- term 
clinical outcomes.
Our study showed a significant increase in hyper-
emic coronary blood flow and improvement in micro-
vascular function a few weeks after the procedure: 
Maximum blood flow increased by 49% and micro-
vascular resistance decreased by 29% at follow- up 
compared with post- PCI. There was an accompanying 
increase in distal vessel diameter and a decrease of 
the epicardial resistance of the CTO artery by 17%. It 
appears that the increase of coronary flow is explained 
by 2 factors: decrease in microvascular resistance and 
distal vessel remodeling reflected by decrease of distal 
epicardial resistance. The increase in blood flow ex-
ceeds the decrease of microvascular resistance as the 
increase in flow results from both a lower epicardial 
and lower microvascular resistance.
Notably, almost all patients showed the phenomena 
described above, but in a few patients (generally mildly) 
increased resistance or decreased absolute flow at fol-
low- up was observed despite normal cardiac magnetic 
resonance. Of the 5 patients with increased resistance 
at follow- up, 4 patients had diabetes mellitus. Werner 
et al5 also reported less or delayed recovery in such 
patients, but these numbers are too small to justify 
Figure 2. Increase of flow and decrease of microvascular 
resistance over time in the CTO vessel.
Overview of all performed measurements in the CTO vessel. A, 
Absolute blood flow measured in the CTO vessel directly after 
PCI and at follow- up. B, Microvascular resistance measured in 
the CTO vessel directly after PCI and at follow- up. CTO indicates 
chronic total occlusion; and PCI, percutaneous coronary 
intervention.
Figure 3. Flow and resistance over time in the donor artery. 
Overview of all performed measurements in the donor vessel.
A, Absolute blood flow measured in the donor vessel before PCI, 
directly after PCI, and at follow- up. B, Microvascular resistance 
measured in the donor vessel before PCI, directly after PCI and 
at follow- up. PCI indicates percutaneous coronary intervention.
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conclusions. Further improvement in flow and resis-
tance may happen over time and will be further investi-
gated in the presently ongoing IMPACT- CTO 2 (Impact 
of Coronary Chronic Total Occlusion Percutaneous 
Coronary Intervention on Culprit Vessel Physiology) 
trial (ClinicalTrials.gov Identifier: NCT03830853).
Previous studies have suggested a sort of “vascular 
wall hibernation” at the distal coronary segments of a 
recanalized CTO and failed response to endothelium- 
dependent and - independent stimuli.6,7 In these 
studies, different hyperemic stimuli were applied imme-
diately after successful CTO PCI and vasomotion was 
assessed; intracoronary administration of nitroglycerin, 
adenosine, and acetylcholine or incremental atrial pac-
ing failed to provoke the expected vessel dilatation. 
The one study that included a follow- up assessment 
suggested transient impairment of vasomotion func-
tion.6 The increase in hyperemic absolute coronary 
blood flow demonstrated in our study can be partially 
explained by the above findings and strongly argues 
for improved distal coronary artery wall function. As 
in our study, it has been previously shown that resto-
ration of flow, shear stress, and vasomotor properties 
lead to increase in distal vessel luminal dimensions 
mainly via external elastic membrane enlargement and 
plaque regression.20,21 Regarding microvascular func-
tion, a previous study by Werner et al5 suggested that 
microvascular dysfunction was frequently observed 
immediately after recanalization of a CTO and recov-
ered over time in most of the cases. In that study, 
Doppler- derived coronary flow reserve (CFR) was used 
to quantify microvascular function. However, coronary 
flow reserve is determined by both the epicardial and 
microcirculatory function. Our study remains the first to 
report sequential invasive measurements of absolute 
microvascular resistance.
In a recently published study by Karamasis et al,10 
comprehensive FFR and collateral FFR measurements 
were performed immediately after CTO PCI and at 
short- term follow- up. The study showed an FFR in-
crease overtime accompanied by significant reduction 
of collateral function as expressed by collateral FFR. 
Furthermore, increased distal vessel diameter and 
“positive remodeling” with a significant increase in dis-
tal luminal diameter was observed. Our study adds es-
sential information regarding microvascular resistance 
to these observations, completing the physiological 
concept.
In the subgroup of patients in whom physiological 
measurements were performed in the predominant 
donor vessel, there was no significant change in the 
hyperemic coronary blood flow immediately after CTO 
or at follow- up. Two recent studies assessed changes 
in the donor artery FFR after CTO PCI and reported 
a small but statistically significant increase.22,23 One 
of them suggested a concomitant reduction in cor-
onary flow assessed by intracoronary Doppler. This 
change was explained by the decrease in the myo-
cardial territory supplied by the donor artery after suc-
cessful recanalization of the CTO vessel. In our study, 
possibly the small number of patients in whom donor 
measurements were performed did not allow a similar 
observation. Regarding microvascular resistance, as 
expected there were no changes in the remote to CTO 
myocardium.
LIMITATIONS
Our study has a number of limitations. First, it involved 
a small number of patients, and the results should 
be considered hypothesis generating and cannot be 
used to generalize the findings to a larger complex 
Table 3. QCA and Physiologic Parameters of the Distal CTO Artery at Baseline and at Follow- Up
Number of Patients (n=25)
Baseline Procedure 
Mean±SD Follow- Up Procedure mean±SD P Value
Quantitative coronary analysis
Segment length, mm 18±6.84 15.78±5.14 0.063
Mean lumen diameter, mm 1.77±0.42 1.99±0.48 0.028
Minimal lumen diameter, mm 1.17±0.39 1.42±0.45 <0.001
Mean lumen gain, mm 0.25±0.49
Percentage mean lumen gain, % 17.53±30.14
Minimal lumen gain, mm 0.26±0.40
Percentage minimal lumen gain, % 30.47±61.63
Physiologic measurements
Absolute blood flow CTO vessel, mL/min 148±53 221±77 <0.001
Epicardial resistance, WU 82±55.4 67.9±48.9 0.155
Microvascular resistance, WU 545±255 387±128 <0.05
Summary values represent mean±SD. CTO indicates chronic total occlusion; and WU, Wood units.
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population undergoing CTO- PCI. The magnitude of 
the changes was variable presumably because of the 
variability in collateral flow, microvascular and coro-
nary artery wall dysfunction, and the amount of via-
ble tissue perfused by the CTO artery. Nevertheless, 
the observations were consistent among most of the 
patients. The vast majority of the recanalized CTO 
vessels involved the right coronary artery. Although 
this reflects current CTO PCI practice, a more equal 
CTO vessel distribution would be more representative 
for the different vascular beds. We did not measure 
coronary wedge pressure, and therefore we couldn’t 
calculate collateral FFR and provide a quantitative 
assessment of collateral blood flow enhancing fur-
ther the interpretation of the observed physiological 
changes.
Also, the follow- up interval was not regular, which 
should be recognized. However, no further proce-
dures were performed before physiological mea-
surements, and if staged PCI was indicated, it took 
place after all study measurements so as not to af-
fect these.
Finally, changes in the distal vessel lumen 
were assessed by quantitative coronary analysis. 
Intracoronary imaging would be more informative, 
as it would allow evaluation of vessel remodeling, 
plaque modification, and stent deployment fea-
tures. The ongoing IMPACT- CTO 2 study combines 
sequential advanced physiological measurements, 
including absolute blood flow and resistance with 
optical coherence tomography in an attempt to pro-
vide further insight in coronary physiology and anat-
omy after CTO PCI.
CONCLUSIONS
This study demonstrates that after successful PCI 
of a chronically occluded coronary artery, physiol-
ogy of the distal coronary artery and microvascula-
ture does not normalize immediately but improves 
significantly within a few months. This is reflected 
by an increase of maximum coronary blood flow of 
49%, decrease of microvascular resistance of the 
myocardium by 29%, and positive remodeling of 
the distal coronary.
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